Actinium

Actinium is the element that defines a family. Just as the lanthanides take their group name from lanthanum, the actinides — the row of 15 heavy elements running from actinium through lawrencium — owe their collective identity to this glowing, intensely radioactive metal. Actinium emits enough radiation to ionize the air around it, and that ionization produces a visible blue glow in the dark, a phenomenon that has fascinated researchers since André-Louis Debierne first separated it from uranium ore in 1899. Despite being discovered more than a century ago, actinium has only recently attracted significant industrial interest, driven by the urgent demand for actinium-225 as a source element for some of the most promising new cancer drugs in development. Producing enough of it to treat patients is now one of the pressing challenges in nuclear medicine.

Actinium-225 is the foundation of a new class of targeted cancer therapies known as targeted alpha therapy. When attached to a molecule that homes in on a specific receptor overexpressed on cancer cells — the most prominent example being PSMA, the prostate-specific membrane antigen found on prostate cancer cells — Ac-225 delivers a cascade of four alpha particles as it decays through its daughter chain. Each alpha particle is extraordinarily destructive within a range of a few cell diameters, making it ideal for eliminating individual tumor cells and micrometastases without the diffuse collateral damage of conventional radiation. Clinical trials of Ac-225-PSMA-617 have shown dramatic responses in patients with metastatic castration-resistant prostate cancer who had exhausted other options. Ac-225 is also being investigated for leukemia, lymphoma, and neuroendocrine tumors. Supply is the limiting factor: most of the world's Ac-225 comes from a handful of nuclear reactors that irradiate radium-226, and demand from clinical trials has repeatedly outstripped availability.

André-Louis Debierne, a close friend and collaborator of Marie and Pierre Curie, discovered actinium in 1899 while working at the same Parisian laboratory where polonium and radium had been identified the year before. He isolated it from the uranium ore residues remaining after the Curies had extracted their elements, noticing that a fraction with unusual chemical properties — it precipitated with the iron group but not with the alkaline earths — also carried intense radioactivity. Debierne named the element actinium from the Greek aktinos, meaning ray or beam, reflecting its powerful radioactivity. Friedrich Giesel, a German chemist, independently isolated the same element in 1902 and called it emanium, not knowing of Debierne's prior work. After some controversy, Debierne's name and discovery date were officially recognized. Actinium's place as the namesake of the actinide series was confirmed in 1945 when Glenn Seaborg proposed the actinide concept as a theoretical framework for the heavy elements.

Actinium-227 occurs naturally in uranium ores as a product of the uranium-235 decay chain. Its concentration in pitchblende is extremely low — roughly one part per ten billion by weight of the ore — because even though it is constantly being produced by the decay of protactinium-231, each Ac-227 atom decays with a half-life of only 21.8 years. A single metric ton of uranium ore contains only about 0.15 milligrams of actinium. Natural sources also include trace amounts in seawater and soil wherever uranium minerals are weathered. There are no extractable deposits and no practical way to mine actinium directly; commercial quantities are produced artificially. The primary method is neutron irradiation of radium-226 targets in nuclear reactors: radium absorbs a neutron to become radium-227, which then beta-decays to actinium-227 over a few weeks. A small amount of Ac-225, the therapeutically important isotope, is also produced by irradiating radium-226 with high-energy protons.

Actinium is a trivalent metal and behaves chemically much like lanthanum, the lightest lanthanide, forming an oxide (Ac2O3), a fluoride (AcF3), a chloride (AcCl3), and an oxychloride (AcOCl) among other compounds. Its fluoride and oxalate are sparingly soluble in water, a property exploited in radiochemical separations. Because actinium is produced in such tiny quantities — typically micrograms to milligrams — its chemistry has been studied mostly by radiochemical tracer methods and more recently by single-atom techniques. The element's ionic radius closely matches that of the rare-earth metals, making separation from lanthanum and its relatives challenging. In targeted alpha therapy, actinium-225 is chelated using macrocyclic ligands such as DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), which bind the Ac3+ ion tightly enough to keep it attached to the targeting antibody or small molecule even as it traverses the bloodstream, preventing free actinium from depositing in bone.

• Actinium glows blue in the dark — not from any intrinsic property of the metal itself, but because its intense alpha and beta radiation ionizes the surrounding air and excites nearby molecules into emitting light, much like the glow inside a plasma ball.
• The entire global supply of actinium-225 available for cancer treatment amounts to only a few curies per year from existing reactor sources, enough to treat a few hundred patients — far short of the demand from ongoing clinical trials.
• Actinium-225 decays through a chain of six steps before reaching stable bismuth-209, releasing four alpha particles in total, making each delivered atom up to six times more destructive than a single-alpha emitter like astatine-211.
• André-Louis Debierne worked in the Curie laboratory for decades but left almost no personal correspondence or memoir, making him one of the most scientifically significant yet historically shadowy figures in the history of radioactivity.
• Because actinium-227 mimics lanthanum in biological systems and concentrates in the skeleton when ingested, it serves as a useful tracer for studying lanthanide uptake and bone metabolism in small-scale research experiments.